Mutations in CD46, a complement regulatory protein, predispose to atypical HUS

Timothy H.J. Goodship, M. Kathryn Liszewski, Elizabeth J. Kemp, Anna Richards, John P. Atkinson

Research output: Contribution to journalReview article

47 Scopus citations


Membrane cofactor protein (MCP, CD46) is a widely expressed transmembrane complement regulator. As does the soluble regulator factor H, it inhibits complement activation by inactivating the C3b that is deposited on target membranes. Factor H mutations have been described in 15-30% of patients with atypical haemolytic uraemic syndrome (HUS). Recent studies have identified mutations in the MCP gene in four families. In one, a heterozygous deletion resulted in the intracellular retention of the mutant protein. In another, a different heterozygous deletion led to a premature stop codon and the loss of the C-terminus. In the other two, a substitution (S206P) resulted in cell-surface expression but inefficient inactivation of surface-bound C3b. These findings provide further evidence that complement dysregulation predisposes to the development of HUS.

Original languageEnglish
Pages (from-to)226-231
Number of pages6
JournalTrends in Molecular Medicine
Issue number5
StatePublished - May 1 2004

Fingerprint Dive into the research topics of 'Mutations in CD46, a complement regulatory protein, predispose to atypical HUS'. Together they form a unique fingerprint.

  • Cite this